Literature DB >> 7631171

Cerebellum and schizophrenia: a selective review.

P Martin1, M Albers.   

Abstract

Structural and functional brain imaging have contributed significant data to our understanding of schizophrenia, but we are still unable to understand the presumably heterogeneous neuronal dysfunctions of schizophrenic disorders. Current disease models define schizophrenia as an exclusively forebrain disorder. Nevertheless, morphological and functional data support the authors' view that cerebellar dysfunction may contribute to schizophrenic disorders. This article presents a critical review of neurological signs, including results of a clinical study performed by the authors, as well as postmortem and neuroimaging findings of cerebellar pathology in schizophrenia patients and studies on other psychiatric features associated with cerebellar lesions. In addition, anatomical, physiological, and behavioral data are reviewed that argue in favor of cerebellar involvement in nonmotor brain functions. A particular cerebellar region, the anterior vermis and corresponding fastigial nucleus, is assumed to be important in schizophrenic disorders, and the neurochemistry and vermian-fastigial-forebrain pathways are shown to correspond well with current hypotheses on neurotransmitter imbalances in schizophrenia. Therapeutic implications are outlined.

Entities:  

Mesh:

Year:  1995        PMID: 7631171     DOI: 10.1093/schbul/21.2.241

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  20 in total

1.  Cerebellar projections to the prefrontal cortex of the primate.

Authors:  F A Middleton; P L Strick
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

Review 2.  Cerebellar arachnoid cyst in a firesetter: the weight of organic lesions in arson.

Authors:  A Heidrich; A Schmidtke; K P Lesch; E Hofmann; T Becker
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

3.  Twitch-related and rhythmic activation of the developing cerebellar cortex.

Authors:  Greta Sokoloff; Alan M Plumeau; Didhiti Mukherjee; Mark S Blumberg
Journal:  J Neurophysiol       Date:  2015-07-08       Impact factor: 2.714

4.  Computed tomographic findings in schizophrenia: relation with symptom dimensions and sex differences.

Authors:  A K Malla; J Takhar; R M Norman; L Assis
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

5.  Isolation of neural stem cells from the postnatal cerebellum.

Authors:  Audra Lee; Jessica D Kessler; Tracy-Ann Read; Constanze Kaiser; Denis Corbeil; Wieland B Huttner; Jane E Johnson; Robert J Wechsler-Reya
Journal:  Nat Neurosci       Date:  2005-05-22       Impact factor: 24.884

Review 6.  Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum.

Authors:  Alexey V Shevelkin; Chinezimuzo Ihenatu; Mikhail V Pletnikov
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

Review 7.  Exploring the cerebellum with a new tool: neonatal Borna disease virus (BDV) infection of the rat's brain.

Authors:  Mikhail V Pletnikov; Steven A Rubin; Timothy H Moran; Kathryn M Carbone
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

Review 8.  The role of the extracellular signal-regulated kinase pathway in cerebellar abnormalities in schizophrenia.

Authors:  Svetlana V Kyosseva
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

9.  Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits.

Authors:  Wulf Hevers; Stephen H Hadley; Hartmut Lüddens; Jahanshah Amin
Journal:  J Neurosci       Date:  2008-05-14       Impact factor: 6.167

10.  Systemic neurochemical alterations in schizophrenic brain: glutamate metabolism in focus.

Authors:  Gulnur Sh Burbaeva; Irina S Boksha; Elena B Tereshkina; Olga K Savushkina; Lubov' I Starodubtseva; Marina S Turishcheva; Elizabeta Mukaetova-Ladinska
Journal:  Neurochem Res       Date:  2007-04-18       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.